MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Auspex Pharmaceuticals Company Profile (NASDAQ:ASPX)

Consensus Ratings for Auspex Pharmaceuticals (NASDAQ:ASPX) (?)
Ratings Breakdown: 6 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $91.00 (9.90% downside)

Analysts' Ratings History for Auspex Pharmaceuticals (NASDAQ:ASPX)
Show:
DateFirmActionRatingPrice TargetActions
3/31/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Stifel NicolausDowngradeBuy -> Hold$101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Robert W. BairdDowngradeOutperform -> Neutral$95.00 -> $101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015William BlairDowngradeOutperform -> Market Perform$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$105.00 -> $101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Piper JaffrayDowngradeOverweight -> Neutral$91.00 -> $101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015William BlairBoost Price TargetOutperform$70.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Stifel NicolausBoost Price TargetBuy$89.00 -> $101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Stifel NicolausBoost Price TargetBuy$61.00 -> $89.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015BMO Capital MarketsBoost Price TargetOutperform$60.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014BMO Capital MarketsBoost Price TargetOutperform$40.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014Stifel NicolausBoost Price TargetBuy$40.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014Piper JaffrayBoost Price Target$72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2014Piper JaffrayInitiated CoverageOverweight$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2014Ladenburg ThalmannInitiated CoverageBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Stifel NicolausBoost Price TargetBuy$39.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2014Robert W. BairdBoost Price TargetOutperform$34.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2014Stifel NicolausBoost Price Target$38.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Stifel NicolausInitiated CoverageBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Robert W. BairdInitiated CoverageOutperform$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014BMO Capital MarketsInitiated CoverageOutperform$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/31/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha